Breakpoint Therapeutics aims to advance the clinical advancement of initial-in-class oncology drugs that interfere with DNA repair service and replication anxiety tolerance pathways. The organization’s therapeutics goal the DNA harm reaction in cancer cells with repair and replication stress tolerance pathways, enabling the professional medical organisation and hospitals to acquire https://is.gd/VVmTMJ